微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 26.78% | 3.24% | -0.18% | 40/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 26.82% | 1.89% | 1.95% | 41/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 26.31% | -0.35% | 1.72% | 40/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 25.86% | -8.53% | -0.28% | 39/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 25.94% | -12.91% | -1.48% | 38/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 26.33% | -15.65% | -0.29% | 40/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 26.4% | -21.31% | -6.63% | 36/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 28.28% | 6.57% | -5.05% | 41/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 29.78% | 14.86% | -4.58% | 42/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 31.21% | 13.68% | -6.98% | 41/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 33.55% | 24.74% | 26.46% | 37/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 26.53% | 10.85% | 2.34% | 44/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 25.93% | 3.56% | -5.56% | 41/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 27.45% | 11.51% | 2.07% | 42/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 26.9% | 18.77% | 12.38% | 36/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 23.94% | -12.87% | -4.39% | 48/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 25.03% | -36.59% | 1.68% | 35/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 24.62% | -44.83% | 8.71% | 45/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 22.65% | -14.11% | -17.56% | 27/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 27.47% | -31.39% | -30.42% | 44/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 39.48% | -18.82% | -11.52% | 20/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 44.62% | -3.23% | 69.23% | 17/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | 26.37% | -28.3% | -34.14% | 22/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 40.04% | -11.9% | -17.67% | 29/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 48.63% | 1.52% | 5.47% | 10/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 46.11% | -5.03% | 25.38% | 14/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 36.78% | -36.19% | -19.08% | 19/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 45.45% | -20.12% | -5.12% | 15/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 47.9% | -25.15% | -1.34% | 9/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 48.55% | -26.95% | -15.76% | 11/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 57.64% | -23.85% | 1.31% | 4/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 56.9% | 41.44% | -11.1% | 5/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 64% | 58.69% | -3.7% | 3/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 66.46% | 74.76% | -12.19% | 2/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 75.69% | 74.77% | 88.16% | 1/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 40.23% | 28.94% | -0.26% | 16/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 40.33% | 45.49% | 6.05% | 10/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 38.03% | 49.53% | -12.18% | 14/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 43.31% | 39.17% | 38.82% | 8/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 31.2% | 118.84% | 12.54% | 22/52 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 27.72% | 133.21% | 8.99% | 15/52 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 25.43% | 70.46% | -18.27% | 15/52 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 31.12% | 2.56% | 118.29% | 11/52 | 24.2% | 睿智医药 | 52.68% | 行业排名> |